Rising BioSciences (RBII) Stock News

Rising Biosciences, Inc. (RBII) announced the acquisition of OXY THYME Southeast, Inc. in a strategic cash and stock deal. This acquisition positions RBII to expand its market presence, as OXY THYME Southeast is the company's largest independent operator. CEO Arthur Hall expressed enthusiasm for working with Brandon Prevatt, the current CEO of OXY THYME, who will help enhance sales channels across multiple states. This move is expected to significantly strengthen RBII's operational capabilities in the healthcare sector.